360 related articles for article (PubMed ID: 18661556)
1. Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology.
Desai MK; Sudol KL; Janelsins MC; Mastrangelo MA; Frazer ME; Bowers WJ
Glia; 2009 Jan; 57(1):54-65. PubMed ID: 18661556
[TBL] [Abstract][Full Text] [Related]
2. Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target.
Desai MK; Mastrangelo MA; Ryan DA; Sudol KL; Narrow WC; Bowers WJ
Am J Pathol; 2010 Sep; 177(3):1422-35. PubMed ID: 20696774
[TBL] [Abstract][Full Text] [Related]
3. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.
Oddo S; Caccamo A; Kitazawa M; Tseng BP; LaFerla FM
Neurobiol Aging; 2003 Dec; 24(8):1063-70. PubMed ID: 14643377
[TBL] [Abstract][Full Text] [Related]
4. Chronic temporal lobe epilepsy is associated with enhanced Alzheimer-like neuropathology in 3×Tg-AD mice.
Yan XX; Cai Y; Shelton J; Deng SH; Luo XG; Oddo S; Laferla FM; Cai H; Rose GM; Patrylo PR
PLoS One; 2012; 7(11):e48782. PubMed ID: 23155407
[TBL] [Abstract][Full Text] [Related]
5. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
[TBL] [Abstract][Full Text] [Related]
6. An Alzheimer's disease-relevant presenilin-1 mutation augments amyloid-beta-induced oligodendrocyte dysfunction.
Desai MK; Guercio BJ; Narrow WC; Bowers WJ
Glia; 2011 Apr; 59(4):627-40. PubMed ID: 21294162
[TBL] [Abstract][Full Text] [Related]
7. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
8. Neurofibrillary tangles and plaques are not accompanied by white matter pathology in aged triple transgenic-Alzheimer disease mice.
Kastyak-Ibrahim MZ; Di Curzio DL; Buist R; Herrera SL; Albensi BC; Del Bigio MR; Martin M
Magn Reson Imaging; 2013 Nov; 31(9):1515-21. PubMed ID: 23993791
[TBL] [Abstract][Full Text] [Related]
9. A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss.
Cohen RM; Rezai-Zadeh K; Weitz TM; Rentsendorj A; Gate D; Spivak I; Bholat Y; Vasilevko V; Glabe CG; Breunig JJ; Rakic P; Davtyan H; Agadjanyan MG; Kepe V; Barrio JR; Bannykh S; Szekely CA; Pechnick RN; Town T
J Neurosci; 2013 Apr; 33(15):6245-56. PubMed ID: 23575824
[TBL] [Abstract][Full Text] [Related]
10. Early-in-life neuroanatomical and behavioural trajectories in a triple transgenic model of Alzheimer's disease.
Kong V; Devenyi GA; Gallino D; Ayranci G; Germann J; Rollins C; Chakravarty MM
Brain Struct Funct; 2018 Sep; 223(7):3365-3382. PubMed ID: 29948190
[TBL] [Abstract][Full Text] [Related]
11. Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice.
Mastrangelo MA; Bowers WJ
BMC Neurosci; 2008 Aug; 9():81. PubMed ID: 18700006
[TBL] [Abstract][Full Text] [Related]
12. Early structural and functional defects in synapses and myelinated axons in stratum lacunosum moleculare in two preclinical models for tauopathy.
Maurin H; Chong SA; Kraev I; Davies H; Kremer A; Seymour CM; Lechat B; Jaworski T; Borghgraef P; Devijver H; Callewaert G; Stewart MG; Van Leuven F
PLoS One; 2014; 9(2):e87605. PubMed ID: 24498342
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
14. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
15. Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease.
Paulson JB; Ramsden M; Forster C; Sherman MA; McGowan E; Ashe KH
Am J Pathol; 2008 Sep; 173(3):762-72. PubMed ID: 18669616
[TBL] [Abstract][Full Text] [Related]
16. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia.
Nguyen TV; Hayes M; Zbesko JC; Frye JB; Congrove NR; Belichenko NP; McKay BS; Longo FM; Doyle KP
Acta Neuropathol Commun; 2018 Sep; 6(1):100. PubMed ID: 30249297
[TBL] [Abstract][Full Text] [Related]
18. Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice.
Bolmont T; Clavaguera F; Meyer-Luehmann M; Herzig MC; Radde R; Staufenbiel M; Lewis J; Hutton M; Tolnay M; Jucker M
Am J Pathol; 2007 Dec; 171(6):2012-20. PubMed ID: 18055549
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1.
Boutajangout A; Authelet M; Blanchard V; Touchet N; Tremp G; Pradier L; Brion JP
Neurobiol Dis; 2004 Feb; 15(1):47-60. PubMed ID: 14751770
[TBL] [Abstract][Full Text] [Related]
20. Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease.
Edwards MM; Rodríguez JJ; Gutierrez-Lanza R; Yates J; Verkhratsky A; Lutty GA
Exp Eye Res; 2014 Oct; 127():252-60. PubMed ID: 25149907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
